NCT00003401View on ClinicalTrials.gov

Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

January 31, 1999

Primary Completion Date

September 30, 2002

Study Completion Date

September 30, 2002

Conditions
Multiple Myeloma and Plasma Cell Neoplasm
Interventions
DRUG

carmustine

DRUG

cisplatin

DRUG

cyclophosphamide

DRUG

dexamethasone

DRUG

etoposide

DRUG

gemcitabine hydrochloride

DRUG

melphalan

DRUG

paclitaxel

PROCEDURE

bone marrow ablation with stem cell support

PROCEDURE

peripheral blood stem cell transplantation

Trial Locations (1)

21201

Marlene & Stewart Greenebaum Cancer Center, University of Maryland, Baltimore

All Listed Sponsors
lead

University of Maryland, Baltimore

OTHER

NCT00003401 - Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma | Biotech Hunter | Biotech Hunter